NIH Highlighted Topic: Strengthening Biomedical Research, Promoting Trust, and Improving Health through Bioethics Research
Below is a brief summary. Please check the full solicitation before applying (link in resources section).
Executive Summary:
The National Institutes of Health (NIH) is encouraging innovative research proposals focused on strengthening biomedical research, improving public trust in science, and advancing actionable bioethics research across biomedical, behavioral, clinical, and data-driven health research ecosystems. This highlighted topic supports multidisciplinary projects designed to integrate ethical principles into emerging technologies, artificial intelligence, genomics, neuroscience, clinical trials, digital health, and data science to improve transparency, autonomy, equity, and long-term public engagement in research.
NIH is particularly interested in projects that address ethical challenges related to AI systems, digital health technologies, informed consent, data sharing, community engagement, participant autonomy, return of research results, privacy, neurotechnology, genomics, and biomedical innovation. Companies developing AI governance platforms, healthcare consent systems, ethical data-sharing infrastructure, digital health ethics tools, research engagement technologies, privacy-preserving analytics systems, or bioethics-focused clinical research platforms may be strong candidates for funding.
Areas of interest include AI transparency and generalizability, ethical design of neurotechnology and biomedical AI systems, genomic privacy, informed consent for wearables and electronic health records, community-centered clinical trial recruitment, ethical use of imaging and biometrics, return-of-results frameworks, health equity, data security, responsible AI deployment, implementation science, and trust-building approaches for underserved and vulnerable populations.
Funding is available through the NIH SBIR/STTR Program and related NIH research mechanisms, with opportunities for Phase I and Phase II commercialization support depending on project scope and translational impact.
This highlighted topic is supported by numerous NIH Institutes and Offices including OSP, BRAIN Initiative, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NIDA, NIDCR, NINDS, ODSS, OBSSR, and others, all of which are seeking transformative innovations that strengthen ethical biomedical research, trustworthy AI, responsible data use, participant engagement, and equitable healthcare innovation.
How much funding would I receive?
Awards provide up to $323,090 for Phase I projects (up to 2 years) and $2,153,927 for Phase II projects (up to 3 years). Some topics approved by NIH may exceed these limits. Fast-Track and Phase IIB (follow-on) options allow continuous or extended funding beyond Phase II.
What could I use the funding for?
Funding may support the research, development, validation, implementation, and commercialization of bioethics technologies, AI governance systems, informed consent platforms, data privacy tools, and community-engagement solutions for biomedical research and healthcare innovation.
Eligible activities may include:
AI governance, transparency, and explainability platforms for healthcare and biomedical research
Ethical data-sharing and privacy-preserving analytics systems
Digital informed consent and participant autonomy technologies
Community engagement and clinical trial recruitment platforms
Ethical AI and neurotechnology assessment tools
Genomics, imaging, and biometric privacy infrastructure
Return-of-results communication and decision-support systems
Research trust-building and public engagement technologies
Data stewardship and FAIR/CARE-aligned research infrastructure
Bioethics analytics and compliance monitoring systems
Ethical frameworks for wearables, EHRs, linked data, and public health research
AI bias detection and generalizability validation platforms
Clinical trial transparency and adaptive research governance technologies
Neuroethics and brain-computer interface ethics platforms
Digital health ethics, implementation science, and health equity technologies
Educational and workforce development tools supporting responsible biomedical innovation
Prototype development, translational studies, and implementation research
Commercialization planning, regulatory preparation, and deployment scaling activities
Funding may also support personnel, software engineering, cloud infrastructure, AI model development, cybersecurity systems, community-engaged research, data governance implementation, usability testing, stakeholder engagement, intellectual property protection, regulatory strategy, and commercialization activities necessary to advance a scalable and commercially viable bioethics or healthcare technology solution aligned with NIH priorities.
Are there any additional benefits I would receive?
Beyond the formal funding award, awardees gain several strategic advantages:
Government Validation and Credibility:
Being selected for an NIH-backed SBIR grant signals technical excellence and alignment with national health and biomedical priorities. This validation builds investor and partner confidence.Enhanced Visibility and Market Recognition:
Awardees are featured in NIH and HHS announcements, helping attract partnerships, media attention, and future contracting opportunities.Access to the Federal Innovation Ecosystem:
Recipients join a national network of researchers and agencies advancing life science innovation, often opening doors to collaborations with NIH laboratories and federal health programs.Stronger Commercial and Exit Potential:
By maturing technology through nondilutive funding, companies strengthen valuation, de-risk commercialization, and increase attractiveness for acquisition or follow-on private investment.
What is the timeline to apply and when would I receive funding?
Applications are accepted each year on January 5th, April 5th, and September 5th. Funding is received approximately 9 months after submission.
Where does this funding come from?
Funding comes from the U.S. Department of Health and Human Services, with statutory set-asides requiring NIH, CDC, and FDA to devote portions of their extramural R&D budgets (3.2% for SBIR, 0.45% for STTR) to support small business innovation.
Who is eligible to apply?
Applicants must be U.S. small business concerns (SBCs) that:
Are organized for profit with a U.S. place of business.
Have ≤ 500 employees including affiliates.
Are > 50% owned by U.S. citizens or permanent residents, qualifying U.S. entities, or combinations thereof.
What companies and projects are likely to win?
Projects that demonstrate:
A clear unmet medical or public-health need,
Strong scientific rationale and feasibility,
High commercialization potential, supported by a realistic market and regulatory strategy, and
Alignment with an NIH Institute’s or CDC/FDA Center’s specific research mission (e.g., infectious disease, digital health, diagnostics, therapeutics, or data analytics).
Competitive applicants often have an early prototype, preliminary data, and a defined path to market adoption.
Are there any restrictions I should know about?
Companies must complete multiple federal registrations (SAM.gov, Grants.gov, eRA Commons, SBA Company Registry) before applying.
Foreign entities are not eligible.
Disclosure of foreign affiliations and compliance with national security screening are mandatory. Currently we do not recommend any sort of foreign affiliation.
How long will it take me to prepare an application?
For a first-time applicant, preparing a competitive submission will likely take 120–200 hours in total.
How can BW&CO help?
Our team specializes in complex federal R&D proposals and can:
Triple your likelihood of success through proven strategy and insider-aligned proposal development
Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations
Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.
